Ownership history in Front Row Advisors LLC Β· 30 quarters on record
This page tracks every 13F SEC filing in which Front Row Advisors LLC reported a position in INTUITIVE SURGICAL INC COM NEW (ISRG). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Front Row Advisors LLC outperformed the S&P 500 by +9.9% annually on this ISRG position. Timing score: 43% (10/23 decisions correct). Average cost basis: $323.88. Maximum drawdown during holding period: β47.8%.
π₯ Exceptional β beat the S&P 500 by 9.9% per year on this position.
28 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
10 of 23 add/trim decisions correct
Best entry: $165.07 (2020 Q1) Β· Worst: $566.36 (2025 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
18 adds Β· 7 trims. Bought during 5 of 10 down-price quarters. π Consistently bullish β fund kept accumulating this position.
π Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 1.21% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size